Abstract
An actinomycete strain No. Q996-17 produced a novel compound, epoxomicin, which exhibited in vivo antitumor activity against B16 melanoma. Structural studies indicated that it is a new member of the epoxy-β-aminoketone group, and is closely related to eponemycin. © 1992, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.
Cite
CITATION STYLE
APA
Hanada, M., Sugawara, K., Kaneta, K., Toda, S., Nishiyama, Y., Tomita, K., … Oki, T. (1992). Epoxomicin, A New Antitumor Agent of Microbial Origin. The Journal of Antibiotics, 45(11), 1746–1752. https://doi.org/10.7164/antibiotics.45.1746
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free